COVID-19 Medicines Optimisation: Specialty Guidance

Summary of COVID-19 medicines guidance: Cardiovascular system disorders

5 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and cardiovascular system disorders. Our…

Summary of COVID-19 medicines guidance: Learning disabilities

30 December 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and learning disabilities. Our advice…

Summary of COVID-19 medicines guidance: Surgery

29 December 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and surgery. This page has…

Summary of COVID-19 medicines guidance: Infection and infectious diseases

29 December 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and infection and infectious diseases.…

Summary of COVID-19 medicines guidance: Renal and urologic disorders

24 December 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and renal and urologic disorders.…

Summary of COVID-19 medicines guidance: Stroke

22 December 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and stroke. Our advice is…

Summary of COVID-19 medicines guidance: Paediatric and neonatal medicine

21 December 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and paediatric and neonatal medicine.…

Summary of COVID-19 medicines guidance: Gastrointestinal disorders

18 December 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and gastrointestinal disorders. Our advice…

Summary of COVID-19 medicines guidance: Eyes and vision

18 December 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and eyes and vision. Our…

Summary of COVID-19 medicines guidance: Endocrine system disorders

15 December 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and endocrine system disorders. Our…